Brooks O'Neil
Stock Analyst at Lake Street
(0.93)
# 3,729
Out of 4,944 analysts
39
Total ratings
31.58%
Success rate
-18.76%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $11.13 | +7.82% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $5.76 | +38.89% | 7 | Aug 11, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $14 | $6.89 | +103.19% | 3 | Aug 6, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $7.10 | +181.69% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $38.03 | +13.07% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $95.15 | +15.61% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $15.10 | +98.68% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $35.57 | +99.61% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $2.25 | +344.44% | 3 | Jan 13, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $14.51 | +79.19% | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $55 | $36.50 | +50.68% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $15.80 | +13.92% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.92 | +1.73% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $7.27 | +65.06% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $19.73 | +31.78% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.73 | +1,404.17% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $40.90 | +211.74% | 1 | Sep 15, 2020 |
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $11.13
Upside: +7.82%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $5.76
Upside: +38.89%
LifeMD
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $14
Current: $6.89
Upside: +103.19%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $7.10
Upside: +181.69%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $38.03
Upside: +13.07%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $95.15
Upside: +15.61%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $15.10
Upside: +98.68%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $35.57
Upside: +99.61%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $2.25
Upside: +344.44%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $14.51
Upside: +79.19%
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $36.50
Upside: +50.68%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $15.80
Upside: +13.92%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.92
Upside: +1.73%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $7.27
Upside: +65.06%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $19.73
Upside: +31.78%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.73
Upside: +1,404.17%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $40.90
Upside: +211.74%